Response to Nivolumab in Metastatic Collecting Duct Carcinoma Expressing PD‑L1: A Case Report

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2017.1449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Collecting Duct Carcinoma of the Kidney: A Case Report

Oncology Letters
Cancer ResearchOncology
2015English

Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably to Nivolumab: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2019English

Medical Image of the Week: Metastatic Collecting Duct Carcinoma

Southwest Journal of Pulmonary and Critical Care
2014English

PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

A Case Report of Collecting Duct Carcinoma of the Kidney Coexistent With Giant Adrenal Myelolipoma

Canadian Urological Association Journal
Urology
2013English

Response to Nab-Paclitaxel and Nedaplatin in a Heavily-Metastatic Thymic Carcinoma: A Case Report

Oncology Letters
Cancer ResearchOncology
2015English

Reply to ‘Challenging PD-L1 Expressing Cytotoxic T Cells as a Predictor for Response to Immunotherapy in Melanoma’

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Collecting Duct of Bellini Renal Carcinoma With Psoas Muscle Recurrence: A Case Report and Review of Literature

Canadian Urological Association Journal
Urology
2014English

Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy